100% Allograft Demineralized Bone Fiber | Osteoinductive Potential | Excellent Handling | Rapid Rehydration | Osteoconductive Scaffold
Cervos Medical developed VelvetDBF™ to deliver a high-performance demineralized bone fiber designed for efficient handling, biologic performance, and broad clinical application.
Composed of 100% allograft cortical bone, VelvetDBF features elongated, interlocking fibers that create an osteoconductive scaffold to support cellular attachment and new bone formation. With verified osteoinductive potential and rapid rehydration using blood, BMA, PRP, or saline, VelvetDBF integrates seamlessly into surgical workflows while conforming to patient anatomy.
Schedule a DemoProvides a cohesive, moldable consistency that shapes easily, resists irrigation, and simplifies graft placement without added carriers.
Demonstrates osteoinductive potential supported by in vitro and in vivo studies, including ALP testing and evidence of new bone formation.
Rapidly hydrates with blood, BMA, PRP, or saline and expands to retain fluid, conforming to patient anatomy and filling bone voids efficiently.
SEM imaging of VelvetDBF illustrates malleable, elongated interwoven fibers, pore sizes of 100 μm+, and a rugged topography to support cellular infiltration, adhesion, and osteoconductivity.
VelvetDBF is intended for repair, replacement, or reconstruction of osseous defects — including filling bone voids or gaps of the skeletal system.
Watch how VelvetDBF hydrates with the surgeon's fluid of choice — blood, BMA, PRP, or saline — and shapes into a cohesive, moldable graft ready for placement.
| Analysis | Sample (N =) | Result (Average) | Control / Threshold |
|---|---|---|---|
| Alkaline Phosphatase (ALP) Activity | 5 Donors | 1.46 | 0.2 (OI assay threshold) |
| BMP-2 Expression (ELISA) | 8 Donors | Statistically higher vs. control | p < 0.001 |
| BMP-7 Expression (ELISA) | 8 Donors | Statistically higher vs. control | p < 0.001 |
| In Vivo Osteoinductive (OI) Score | 12 Donors | ~2 | p < 0.001 |
Data derived from in vitro and in vivo testing, including ALP assays, ELISA quantification of BMP-2 and BMP-7, and an ASTM athymic nude rat model. Results demonstrate osteoinductive potential and are not intended to represent human clinical outcomes.
View the VelvetDBF™ Scientific White Paper for detailed methodology and preclinical evidence supporting osteoinductive potential.
| Product # | Catalog Code | Product Name |
|---|---|---|
| 01106-01P | VelvetDBF 5CC | 5 cc VelvetDBF (Demineralized Bone Fiber), sterile |
| 01107-01P | VelvetDBF 10CC | 10 cc VelvetDBF (Demineralized Bone Fiber), sterile |
| 77134-01M | HydraCell-ORTHO-5 | HydraCell Overbox: one sterile 5 cc VelvetDBF and one sterile CER-ORTHO-M device |
| 77135-01M | HydraCell-ORTHO-10 | HydraCell Overbox: one sterile 10 cc VelvetDBF and one sterile CER-ORTHO-M device |
| 77136-01M | HydraCell-EXT-5 | HydraCell Overbox: one sterile 5 cc VelvetDBF and one sterile CER-EXT-M device |
| 77137-01M | HydraCell-EXT-10 | HydraCell Overbox: one sterile 10 cc VelvetDBF and one sterile CER-EXT-M device |
Discover the clinical advantages of high-performance demineralized bone fiber.
Schedule a Demo